A naukri.com initiative
Bioengineer
5d
81
Image Credit: Bioengineer
Berbamine Boosts FTO to Halt Kidney Cancer
- A recent study has highlighted the potential of berbamine (BBM) in inhibiting the proliferation and invasion of renal cell carcinoma (RCC) cells by boosting the expression of the fat mass and obesity-associated gene (FTO).
- Berbamine, derived from Berberis amurensis, demonstrated significant anti-tumor effects in RCC cell lines, offering a promising avenue for novel therapeutics against metastatic RCC.
- Through in vitro and in vivo experiments, berbamine exhibited dose-dependent inhibition of RCC cell growth, impeded colony formation, disrupted cell cycle progression, and reduced migratory and invasive capabilities.
- The study revealed that berbamine enhances FTO expression at mRNA and protein levels, with FTO acting as a crucial mediator of berbamine's anti-tumor activity in RCC cells.
- Silencing FTO attenuated berbamine's inhibitory effects on RCC cell growth and invasion, emphasizing the significance of the FTO pathway as a potential target for therapeutic intervention.
- In animal models, berbamine significantly suppressed tumor growth without systemic toxicity, positioning it as a promising candidate for clinical development against RCC.
- The research sheds light on berbamine's intricate mechanisms within the RCC microenvironment, highlighting the role of epitranscriptomic regulation in cancer biology and offering a novel approach for cancer treatment.
- The study's findings underscore the therapeutic potential of berbamine in addressing critical aspects of RCC aggressiveness and metastasis, presenting a paradigm shift in combating this challenging malignancy.
- Further research is needed to elucidate the specific downstream targets of FTO influenced by berbamine treatment, paving the way for the development of personalized and effective therapeutic strategies in RCC.
- With its low toxicity profile and natural origin, berbamine holds promise for translational efforts towards clinical trials, offering hope for innovative and biologically inspired therapies for metastatic RCC.
Read Full Article
4 Likes
For uninterrupted reading, download the app